Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hayahara

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|June 9, 1992
Expression of hepatic microsomal cytochrome P450s as altered by uremiaS Ikemoto, S Imaoka, N Hayahara, et al.
Clinical and Experimental Immunology|June 1, 1990
Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vitroS Ikemoto, T Kishimoto, S Wada, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytesS Ikemoto, S Wada, M Kamizuru, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 1, 1989
[Blind-ending bifid ureter: 3 case reports]Y Takemoto, M Nariyama, Y Morikawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1983
[A new method to assay urinary oxalic acid using high-performance liquid chromatography]T Sugimoto, S Nishio, M Maekawa, et al.
British Journal of Urology|February 1, 1990
Defective interleukin-1 production of monocytes in patients with bladder cancerS Ikemoto, T Kishimoto, H Iimori, et al.
Urology|December 1, 1992
Combined effect of interleukin 2 and cyclophosphamide in therapy of mice with transitional cell carcinomaS Ikemoto, M Kamizuru, S Wada, et al.
Clinical and Experimental Immunology|February 1, 1992
Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivoS Ikemoto, M Kamizuru, N Hayahara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1992
[Combined effect of TNF and anticancer chemotherapeutic agents on murine bladder tumor (MBT-2)]S Ikemoto, H Iimori, K Nishimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 7, 1998
[A case of renal pelvic cancer with high serum level of CA 19-9]H Iwata, T Sugimoto, T Asai, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|June 9, 1992
Expression of hepatic microsomal cytochrome P450s as altered by uremiaS Ikemoto, S Imaoka, N Hayahara, et al.
Clinical and Experimental Immunology|June 1, 1990
Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vitroS Ikemoto, T Kishimoto, S Wada, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytesS Ikemoto, S Wada, M Kamizuru, et al.
Hinyokika Kiyo. Acta Urologica Japonica|January 1, 1989
[Blind-ending bifid ureter: 3 case reports]Y Takemoto, M Nariyama, Y Morikawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1983
[A new method to assay urinary oxalic acid using high-performance liquid chromatography]T Sugimoto, S Nishio, M Maekawa, et al.
British Journal of Urology|February 1, 1990
Defective interleukin-1 production of monocytes in patients with bladder cancerS Ikemoto, T Kishimoto, H Iimori, et al.
Urology|December 1, 1992
Combined effect of interleukin 2 and cyclophosphamide in therapy of mice with transitional cell carcinomaS Ikemoto, M Kamizuru, S Wada, et al.
Clinical and Experimental Immunology|February 1, 1992
Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivoS Ikemoto, M Kamizuru, N Hayahara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1992
[Combined effect of TNF and anticancer chemotherapeutic agents on murine bladder tumor (MBT-2)]S Ikemoto, H Iimori, K Nishimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 7, 1998
[A case of renal pelvic cancer with high serum level of CA 19-9]H Iwata, T Sugimoto, T Asai, et al.
Pageof 4